نتائج البحث - "Jessica C. Hassel"

وصف الملف: 657_Zimmer L. et al._Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD1 Therapy_EJC 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1556fdca6ff1cf1a91650c07c15aefTest
https://doi.org/10.1016/j.ejca.2016.02.024Test

6

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

المؤلفون: Ralf Gutzmer, Claudia Pföhler, Lucie Heinzerling, Friedegund Meier, Patrick Terheyden, Anika Koop, Katharina C. Kähler, Anja Gesierich, Imke Satzger, Jessica C. Hassel, Selma Ugurel, Elisabeth Livingstone, Lisa Zimmer

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Programmed Cell Death 1 Receptor, Medizin, Antineoplastic Agents, Autoimmunity, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, medicine.disease_cause, Group B, Autoimmune Diseases, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Internal medicine, medicine, Humans, Neoplasm Metastasis, Adverse effect, Melanoma, Aged, Retrospective Studies, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Clinical trial, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Immunology, Female, Skin cancer, business, Immunosuppressive Agents, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f231eef4f538a01b10c7b953cfdcb2Test
https://www.ncbi.nlm.nih.gov/pubmed/28214654Test

7

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

المصدر: JAMA Oncol

مصطلحات موضوعية: advanced melanoma, Adult, Male, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Time Factors, Adolescent, Dacarbazine, Medizin, Phases of clinical research, Ipilimumab, Pembrolizumab, Placebo, BRAF, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Double-Blind Method, Internal medicine, medicine, Humans, 030212 general & internal medicine, Nivolumab, wild-type, Antineoplastic Agents, Alkylating, Melanoma, Aged, Aged, 80 and over, business.industry, Hazard ratio, Correction, Middle Aged, medicine.disease, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Disease Progression, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c9b0d0b1e4e0e7e07096a725b4e567Test
https://doi.org/10.1001/jamaoncol.2018.4514Test

8

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

المصدر: European journal of cancer (Oxford, England : 1990). 60

مصطلحات موضوعية: 0301 basic medicine, Adult, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Gastrointestinal Diseases, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Antineoplastic Agents, Pembrolizumab, Antibodies, Monoclonal, Humanized, Endocrine System Diseases, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Endocrine system, Medicine, Humans, Melanoma, Aged, Retrospective Studies, Gastrointestinal tract, business.industry, Cancer, Antibodies, Monoclonal, Middle Aged, medicine.disease, 030104 developmental biology, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Immunology, Female, Kidney Diseases, Drug Eruptions, Skin cancer, Chemical and Drug Induced Liver Injury, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263bce5158d70c2cbeead10f02368ef9Test
https://pubmed.ncbi.nlm.nih.gov/27085692Test

9

Improved survival with ipilimumab in patients with metastatic melanoma

المساهمون: Medical oncology, CCA - Innovative therapy

المصدر: New England Journal of Medicine, 363(8), 711-723. Massachussetts Medical Society
Hodi, F S, O'Day, S J, McDermott, D F, Weber, R W, Sosman, J A, Haanen, JB, Gonzalez, R, Robert, C, Schadendorf, D, Hassel, J C, Akerley, W, van den Eertwegh, A J M, Lutzky, J, Lorigan, P, Vaubel, J M, Linette, G P, Hogg, D, Ottensmeier, C H, Lebbe, C, Peschel, C, Quirt, I, Clark, J I, Wolchok, J D, Weber, J S, Tian, J, Yellin, M J, Nichol, G M, Hoos, A & Urba, WJ 2010, ' Improved Survival with Ipilimumab in Patients with Metastatic Melanoma ', New England Journal of Medicine, vol. 363, no. 8, pp. 711-723 . https://doi.org/10.1056/NEJMoa1003466Test
University of Manchester-PURE

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879e8b03cb2c724046865af964c73435Test
https://pubmed.ncbi.nlm.nih.gov/21938386Test

10

Pooled analysis safety profile of nivolumab and ipilimumab combination therapy in patients with advanced melanoma

المصدر: Scopus-Elsevier
Journal of Clinical Oncology, 35, 34, pp. 3815-3822
Journal of Clinical Oncology, 35, 3815-3822

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Skin Neoplasms, Gastroenterology, 0302 clinical medicine, Melanoma, Randomized Controlled Trials as Topic, Clinical Trials, Phase I as Topic, Antibodies, Monoclonal, Middle Aged, Prognosis, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Drug Therapy, Combination, Female, Patient Safety, medicine.drug, Adult, medicine.medical_specialty, Combination therapy, Maximum Tolerated Dose, Ipilimumab, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Clinical Trials, Phase II as Topic, All institutes and research themes of the Radboud University Medical Center, Internal medicine, medicine, Humans, Neoplasm Invasiveness, Adverse effect, Survival analysis, Aged, Neoplasm Staging, Retrospective Studies, Dose-Response Relationship, Drug, business.industry, Survival Analysis, Surgery, Discontinuation, Clinical trial, Regimen, 030104 developmental biology, Clinical Trials, Phase III as Topic, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a6e368a7d98d5887d4282ecdf390cbTest
http://www.scopus.com/inward/record.url?eid=2-s2.0-85034087223&partnerID=MN8TOARSTest

تنقيح النتائج